With our pioneering synthetic technology, we are unlocking new frontiers of nucleoside analog building blocks to drive a revolution in antisense oligonucleotide therapies. We're a team of passionate chemists, with a mission to use our expertise to turn a segment of the healthcare industry on it's head to help patients suffering from neurodegenerative diseases.
Company Details
- Employees
- 3
- Founded
- -
- Address
- 8999 Nelson Way, Burnaby,british Columbia V5a 1s6,canada
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.cloudburstbiotech.ca
- Keywords
- nucleoside analog synthesis, sustainable synthesis, medicinal chemistry, biology, Process chemistry, antisense oligonucleotides, neurodegenerative disease therapies.
- HQ
- Burnaby, British Columbia
Cloudburst Biotech Questions
Cloudburst Biotech's website is http://www.cloudburstbiotech.ca
Cloudburst Biotech's LinkedIn profile is https://ca.linkedin.com/company/cloudburstbiotech
Cloudburst Biotech has
3 employees.
View email and phone details for 3
employees at Cloudburst Biotech.
Cloudburst Biotech's industry is
Biotechnology Research
Cloudburst Biotech's top competitors are
Navesta Pharmaceuticals,
Borealis Biosciences, Inc.,
Pharma Inventor Inc.,
Brilliantstrings Therapeutics,
Azor Biotek,
Technology Licensing Office (Tlo) @ Sfu,
Abcellera,
Hydron Energy Inc,
Tc Scientific Inc.,
Simon Fraser University - Department Of Chemistry.
Cloudburst Biotech's categories are Biotechnology Research
Cloudburst Biotech's founding year is 2023
